GlobalData on MSN
Kainova reports positive top line results from Phase I EPRAD trial
The study demonstrated a favourable safety profile for DT-9081.
Researchers explored the effect of immune checkpoint inhibitors on psoas muscle density and skeletal muscle index in patients with melanoma.
Virus-associated cancers are a significant and persistent global health challenge, providing unique insight into the relationship between chronic infection ...
News-Medical.Net on MSN
Microbial ecosystems influence success of cancer checkpoint immunotherapy
Immune checkpoint inhibitors targeting PD-1 and PD-L1 have revolutionized cancer therapy, delivering long-term survival benefits in several malignancies. However, nearly half of patients show limited ...
Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...
Adding the immune checkpoint inhibitors (ICIs) ipilimumab and nivolumab to percutaneous hepatic perfusion may improve survival outcomes in patients with ...
Immune system activation and activity is regulated through stimulatory or inhibitory ligand-receptor interactions collectively termed immune checkpoints. 1 Stimulatory interactions give the immune ...
Skin cancers, lung cancers, lymphomas—though these cancers affect different parts of the body, they can all be treated with one of the latest therapies medicine has to offer: checkpoint inhibitors.
For patients with advanced melanoma without BRAF mutation who no longer respond to immune checkpoint inhibitors, treatment ...
News-Medical.Net on MSN
Discovery offers hope for reducing immune-related heart risks in cancer patients
For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results